Renal clearance of quantum dots
Top Cited Papers
Open Access
- 23 September 2007
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (10) , 1165-1170
- https://doi.org/10.1038/nbt1340
Abstract
The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by >15 nm and prevented renal excretion. A final hydrodynamic diameter <5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.Keywords
This publication has 25 references indexed in Scilit:
- On the Benefit of Bivalency in Peptide Ligand/Pin1 InteractionsJournal of Molecular Biology, 2007
- Production of Multimeric Prostate-Specific Membrane Antigen Small-Molecule Radiotracers Using a Solid-Phase 99mTc Preloading StrategyJournal of Nuclear Medicine, 2007
- An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate‐specific membrane antigen small molecule derivativesContrast Media & Molecular Imaging, 2006
- Synthesis of Compact Multidentate Ligands to Prepare Stable Hydrophilic Quantum Dot FluorophoresJournal of the American Chemical Society, 2005
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003
- Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant ProteinJournal of the American Chemical Society, 2000
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition in English, 1998
- (CdSe)ZnS Core−Shell Quantum Dots: Synthesis and Characterization of a Size Series of Highly Luminescent NanocrystallitesThe Journal of Physical Chemistry B, 1997
- Lysozyme turnover in the ratJournal of Clinical Investigation, 1971
- Metabolism of Bence Jones Proteins*Journal of Clinical Investigation, 1964